RaySearch Laboratories AB (publ) logo

RAY B - RaySearch Laboratories AB (publ) Share Price

SEK90.8 -0.2  -0.2%

Last Trade - 8:51am

Small Cap
Market Cap £267.8m
Enterprise Value £265.9m
Revenue £55.9m
Position in Universe 632nd / 1827
Unlock RAY B Revenue
Relative Strength (%)
1m -5.17%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -19.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
397.6 531.5 585.1 627.2 741.6 651.6 827 940 +10.4%
+17.3 +115.7 -22.3 -33.2 -35.8 +37.1
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020,RaySearch Laboratories AB (publ) revenues decreased 12% toSEK651.6M. Net loss totaled SEK9.1M vs. income of SEK50.4M.Revenues reflect a decrease in demand for the Company'sproducts and services due to unfavorable market conditions.Net loss reflects Operating Exchange Loss increase fromSEK8.2M to SEK47.4M (expense), Amortization in R&D increaseof 21% to SEK137.2M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for RAY B
Graphical History


RAY B Revenue Unlock RAY B Revenue

Net Income

RAY B Net Income Unlock RAY B Revenue

Normalised EPS

RAY B Normalised EPS Unlock RAY B Revenue

PE Ratio Range

RAY B PE Ratio Range Unlock RAY B Revenue

Dividend Yield Range

RAY B Dividend Yield Range Unlock RAY B Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
RAY B EPS Forecasts Unlock RAY B Revenue
Profile Summary

RaySearch Laboratories publ AB is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Public Since May 29, 1990
No. of Shareholders: n/a
No. of Employees: 403
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 34,282,773
Free Float (0.0%)
Eligible for
RAY B Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for RAY B
Upcoming Events for RAY B
Wednesday 30th June, 2021 Estimate
RaySearch Laboratories AB (publ) Annual Shareholders Meeting
Frequently Asked Questions for RaySearch Laboratories AB (publ)
What is the RaySearch Laboratories AB (publ) share price?

As of 8:51am, shares in RaySearch Laboratories AB (publ) are trading at SEK90.8, giving the company a market capitalisation of £267.8m. This share price information is delayed by 15 minutes.

How has the RaySearch Laboratories AB (publ) share price performed this year?

Shares in RaySearch Laboratories AB (publ) are currently trading at SEK90.8 and the price has moved by 60.49% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the RaySearch Laboratories AB (publ) price has moved by 21.89% over the past year.

What are the analyst and broker recommendations for RaySearch Laboratories AB (publ)?

Of the analysts with advisory recommendations for RaySearch Laboratories AB (publ), there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for RaySearch Laboratories AB (publ) is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will RaySearch Laboratories AB (publ) next release its financial results?

RaySearch Laboratories AB (publ) is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the RaySearch Laboratories AB (publ) dividend yield?

RaySearch Laboratories AB (publ) does not currently pay a dividend.

Does RaySearch Laboratories AB (publ) pay a dividend?

RaySearch Laboratories AB (publ) does not currently pay a dividend.

When does RaySearch Laboratories AB (publ) next pay dividends?

RaySearch Laboratories AB (publ) does not currently pay a dividend.

How do I buy RaySearch Laboratories AB (publ) shares?

To buy shares in RaySearch Laboratories AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of RaySearch Laboratories AB (publ)?

Shares in RaySearch Laboratories AB (publ) are currently trading at SEK90.8, giving the company a market capitalisation of £267.8m.

Where are RaySearch Laboratories AB (publ) shares listed? Where are RaySearch Laboratories AB (publ) shares listed?

Here are the trading details for RaySearch Laboratories AB (publ):

Country of listing: Sweden
Exchange: STO
Ticker Symbol: RAY B
What kind of share is RaySearch Laboratories AB (publ)?

Based on an overall assessment of its quality, value and momentum, RaySearch Laboratories AB (publ) is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a RaySearch Laboratories AB (publ) share price forecast 2021?

Shares in RaySearch Laboratories AB (publ) are currently priced at SEK90.8. At that level they are trading at 15.38% discount to the analyst consensus target price of 0.00.

Analysts covering RaySearch Laboratories AB (publ) currently have a consensus Earnings Per Share (EPS) forecast of 2.05 for the next financial year.

How can I tell whether the RaySearch Laboratories AB (publ) share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like RaySearch Laboratories AB (publ). Over the past six months, the relative strength of its shares against the market has been -9.21%. At the current price of SEK90.8, shares in RaySearch Laboratories AB (publ) are trading at 4.54% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the RaySearch Laboratories AB (publ) PE Ratio?

We were not able to find PE ratio data for RaySearch Laboratories AB (publ).

Who are the key directors of RaySearch Laboratories AB (publ)?

RaySearch Laboratories AB (publ)'s management team is headed by:

Johan Lof - CEO
Carl Bergendal - IND
Hans Wigzell - IND
Bjorn Hardemark - DCE
Henrik Friberger - OTH
Peter Kemlin - DSL
Niclas Borglund - OTH
Peter Thysell - CFO
Kjell Eriksson - CSO
Johanna Oberg - IND
Petra Jansson - GCN
Britta Wallgren - IND
Lars Wollung - CHM
David Hedfors - OTH
Who are the major shareholders of RaySearch Laboratories AB (publ)?

Here are the top five shareholders of RaySearch Laboratories AB (publ) based on the size of their shareholding:

Invesco Global Opportunities Fund Mutual Fund
Percentage owned: 15.49% (4.00m shares)
Invesco Advisers, Inc. Investment Advisor
Percentage owned: 15.49% (4.00m shares)
Swedbank Robur Fonder AB Investment Advisor/Hedge Fund
Percentage owned: 8.52% (2.20m shares)
Första AP-Fonden Pension Fund
Percentage owned: 7.68% (1.98m shares)
Swedbank Robur Ny Teknik Mutual Fund
Percentage owned: 6.81% (1.76m shares)
Similar to RAY B
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.